Nvelop Therapeutics
Cambridge
About Nvelop Therapeutics
Nvelop Therapeutics focuses on creating advanced, programmable delivery systems designed for efficient in vivo gene editing and therapeutic cargo delivery. The company combines epigenetic editing technologies with next-generation delivery methods to address unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $100.0M
- Funding stage: M&A
- Last round: Seed (Sep 2023)
- Website: nveloptx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/nvelop-therapeutics-41009 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.